Holdings

Bellevue Group AG

As of Sep 30, 2026, Bellevue Group AG reported 143 positions worth US$4.64B. Largest: Amgen Inc., Gilead Sciences, Inc. and Vertex Pharmaceuticals Incorporated. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Amgen Inc.862KUS$363M+10,140Sep 30, 2026
Gilead Sciences, Inc.2.15MUS$321M−8,080Sep 30, 2026
Vertex Pharmaceuticals Incorporated579KUS$302M−102Sep 30, 2026
argenx SE291KUS$279M−10,493Sep 30, 2026
Regeneron Pharmaceuticals, Inc.280KUS$212M+122KSep 30, 2026
Revolution Medicines, Inc.999KUS$205M−49,064Sep 30, 2026
Insmed Incorporated1.51MUS$172M+115KSep 30, 2026
Viridian Therapeutics, Inc.7.11MUS$146M+377KSep 30, 2026
Oruka Therapeutics, Inc.1.64MUS$137M−16,131Sep 30, 2026
Biogen Inc.598KUS$135M+598KSep 30, 2026